ATTAIN - ABATACEPT TRIAL IN TREATMENT OF ANTI-TNF INADEQUATE RESPONDERS
USPTO (United States) · Serial 78416532
- Status
- cancelled
- Status updated
- 25 September 2015
- Filing date
- 11 May 2004
- Registration date
- 24 February 2009
- Nice classification
- 42
- Owner
- Bristol-Myers Squibb Company
- Owner country
- US
- Raw status code
- 710
As filed by US
Authoritative source
The official US trademark record is at USPTO TSDR (serial 78416532) ↗. Where our data differs from the USPTO record, theirs is correct.
See methodology for refresh cadence + status normalisation. See sources for licensing.